List of works - Santiago Perez-Lloret

A Pilot Cross-Sectional Study to Investigate the Biomarker Potential of Phosphorylated Neurofilament-H and Immune Mediators of Disability in Patients With 5 Year Relapsing-Remitting Multiple Sclerosis

scientific article published on 09 October 2019

A cross-sectional study on drug use in multiple system atrophy

scientific article published on May 2014

A double blind-placebo controlled study on melatonin efficacy to reduce anxiolytic benzodiazepine use in the elderly

scientific article published in February 2002

A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patients ⬇️

scientific article published on November 15, 2011

A multi-step pathway connecting short sleep duration to daytime somnolence, reduced attention, and poor academic performance: an exploratory cross-sectional study in teenagers

scientific article published on 15 May 2013

A multifactorial study on nutritional status, binge eating and physical activity as main factors directly influencing body weight in Parkinson's disease

scientific article

A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson’s disease

scientific article published on 18 May 2011

Actigraphic evaluation of motor fluctuations in patients with Parkinson's disease

scientific article published in February 2010

Activity-rest rhythm abnormalities in Parkinson's disease patients are related to dopaminergic therapy

scientific article published in January 2010

Addenbrooke's Cognitive Examination validation in Parkinson's disease

scientific article published on 25 November 2008

Adverse drug reactions to dopamine agonists: a comparative study in the French Pharmacovigilance Database

scientific article published on September 2010

Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease: an old drug revisited ⬇️

scientific article published on February 11, 2013

Assessment of Ataxia Rating Scales and Cerebellar Functional Tests: Critique and Recommendations

scientific article published on 06 October 2020

Associations Between Cardiovascular Events and Nonergot Dopamine Agonists in Parkinson's Disease

scientific article published on 24 December 2015

Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease

scientific article

Autosomal dominant cerebellar ataxias: a systematic review of clinical features

scientific article

Brief review: diurnal rhythms, obesity and educational achievement in South american cultures.

scientific article published on January 2009

Cardiac autonomic activity predicts dominance in verbal over spatial reasoning tasks: Results from a preliminary study ⬇️

scientific article published on November 25, 2011

Cerebroventricular administration of interferon-gamma modifies locomotor activity in the golden hamster

scientific article published in March 2003

Comparison of Olfactory Identification Patterns among Parkinson's Disease Patients from Different Countries.

scientific article published on 28 October 2015

Correction to: Excessive buccal saliva in patients with Parkinson's disease of the French COPARK cohort

scientific article published on 21 October 2020

Current Concepts in the Treatment of Multiple System Atrophy

scientific article published on 02 February 2015

Decision-making in Parkinson's disease patients with and without pathological gambling

scientific article published on 23 September 2009

Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease

scientific article

Design and development of a novel supportive care product for the treatment of sialorrhea in Parkinson's disease

scientific article published on January 2015

Disruption of ultradian and circadian rhythms of blood pressure in nondipper hypertensive patients

scientific article published on 26 July 2004

Do Parkinson’s disease patients disclose their adverse events spontaneously? ⬇️

scientific article published on December 29, 2011

Does clinical intolerance to a diagnostic acute levodopa challenge differentiate multiple system atrophy from PD?

scientific article published in January 2009

Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinsonʼs Disease

scientific article published on November 1, 2010

Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases

scientific article published on 07 February 2019

Drug-induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France

scientific article published on 14 June 2011

Drugs associated with restless legs syndrome: a case/noncase study in the French Pharmacovigilance Database

scientific article published on December 2012

Dyskinesias induced by subthalamotomy in Parkinson's disease are unresponsive to amantadine

scientific article

Effect of melatonin on changes in locomotor activity rhythm of Syrian hamsters injected with beta amyloid peptide 25-35 in the suprachiasmatic nuclei

scientific article published in December 2002

Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia

scientific article published on 07 March 2018

Emerging analgesic drugs for Parkinson's disease ⬇️

scientific article published on April 25, 2012

Emerging drugs for autonomic dysfunction in Parkinson's disease ⬇️

scientific article published on February 1, 2013

Excessive buccal saliva in patients with Parkinson's disease of the French COPARK cohort

scientific article published on 02 September 2020

Factors related to orthostatic hypotension in Parkinson's disease

scientific article published on 13 February 2012

Falls in ambulatory non-demented patients with Parkinson's disease

scientific article published on 7 April 2015

Gender differences in age-related increase of asleep blood pressure.

scientific article published on 15 July 2009

Heart rate nonlinear dynamics during sudden hypoxia at 8230 m simulated altitude

scientific article

Infradian awake and asleep systolic and diastolic blood pressure rhythms in humans

scientific article published on 01 July 2006

Investigational drugs for autonomic dysfunction in Parkinson's disease

scientific article published on 12 January 2016

Irritability, psychomotor agitation and progressive insomnia induced by bilateral stimulation of the area surrounding the dorsal subthalamic nucleus (zona incerta) in Parkinson's disease patients

scientific article published in December 2009

L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey

scientific article

Management of constipation in Parkinson's disease

scientific article published on 25 December 2014

Movement Disorders After Exposure to Antipsychotic Drugs in Patients With Depressive Disorders

scientific article published on 01 September 2018

Movement Disorders in Autosomal Dominant Cerebellar Ataxias: A Systematic Review.

scientific article

New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study.

scientific article published on 14 May 2015

New treatments for levodopa-induced motor complications

scientific article published on 21 August 2015

Nocturnal hypertension defined by fixed cut-off limits is a better predictor of left ventricular hypertrophy than non-dipping

scientific article published on 15 June 2007

Non-ergot dopamine agonists and the risk of heart failure and other adverse cardiovascular reactions in Parkinson's disease

scientific article

Nonmotor symptoms groups in Parkinson's disease patients: results of a pilot, exploratory study

scientific article

Olfactory Dysfunction Evaluation Is Not Affected by Comorbid Depression in Parkinson's Disease

scientific article published on 11 June 2015

Oro‐buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson’s disease: preliminary analysis from the French COPARK cohort ⬇️

scientific article published on April 1, 2011

Parkinson disease: Serotonin reuptake inhibitors for depression in PD.

scientific article published on 5 June 2012

Parkinson's Disease in the Era of a Novel Respiratory Virus Pandemic

scientific article published on 11 September 2020

Parkinson's disease sleep scale, sleep logs, and actigraphy in the evaluation of sleep in parkinsonian patients

scientific article

Pharmacotherapies for Parkinson's disease symptoms related to cholinergic degeneration

scientific article

Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease

scientific article published on 25 June 2016

Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease ⬇️

scientific article published on September 1, 2010

Pramipexole for the treatment of early Parkinson’s disease ⬇️

scientific article published on July 1, 2011

Predictors of Cardiovascular Autonomic Neuropathy Onset and Progression in a Cohort of Type 1 Diabetic Patients.

scientific article

Pregabalin Beneficial Effects on Sleep Quality or Health-Related Quality of Life Are Poorly Correlated With Reduction on Pain Intensity After an 8-Week Treatment Course ⬇️

scientific article published on January 1, 2012

Pregabalin-induced parkinsonism: a case report

scientific article published in November 2009

Prevalence and Pharmacological Factors Associated With Impulse-Control Disorder Symptoms in Patients With Parkinson Disease ⬇️

scientific article published on 01 November 2012

Prevalence and factors related to orthostatic syndromes in recently diagnosed, drug-naïve patients with Parkinson disease

scientific article published on 17 December 2019

Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease

scientific article published in July 2014

Prospective randomized 1-year follow-up comparison of bilateral subthalamotomy versus bilateral subthalamic stimulation and the combination of both in Parkinson's disease patients: a pilot study.

scientific article published on 01 June 2008

Rating Scales for Pain in Parkinson's Disease: Critique and Recommendations

scientific article published on 24 June 2016

Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson's disease

scientific article

Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients

scientific article published on March 2014

Role of Astrocytic Dysfunction in the Pathogenesis of Parkinson's Disease Animal Models from a Molecular Signaling Perspective

scientific article published on 07 February 2020

Rotigotine transdermal delivery for the treatment of Parkinson's disease

scientific article published on 01 March 2009

Rotigotine transdermal patch for the treatment of Parkinson’s Disease ⬇️

scientific article published on 09 February 2012

Safety of rasagiline for the treatment of Parkinson's disease ⬇️

scientific article published on April 1, 2011

Sensory abnormalities and pain in Parkinson disease and its modulation by treatment of motor symptoms

scientific article published on 06 July 2015

Sleep disordered breathing and daytime sleepiness are associated with poor academic performance in teenagers. A study using the Pediatric Daytime Sleepiness Scale (PDSS).

scientific article published on December 2007

Sleep habits, alertness, cortisol levels, and cardiac autonomic activity in short-distance bus drivers: differences between morning and afternoon shifts

scientific article published in July 2011

State-of-the-art pharmacotherapy for autonomic dysfunction in Parkinson's disease

scientific article published on 20 January 2020

Subjective sleep dysfunction and insomnia symptoms in Parkinson's disease: Insights from a cross-sectional evaluation of the French CoPark cohort

scientific article

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

scientific article

The Parkinson's disease pain classification system (PDPCS): results from an international mechanism-based classification approach

scientific article published on 08 October 2020

The safety and efficacy of safinamide mesylate for the treatment of Parkinson's disease

scientific article

Therapeutic strategies for Parkinson's disease: promising agents in early clinical development

scientific article published on 27 August 2020

Trends in inpatient antiparkinson drug use in the USA, 2001-2012.

scientific article published on 18 June 2015

Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant

scientific article published on 27 March 2014

Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review

scientific article published on 17 January 2019

Utilization Patterns of Amantadine in Parkinson's Disease Patients Enrolled in the French COPARK Study

scientific article published on 01 March 2020

Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease

scientific article published in January 2007

Validation of a new scale to assess olfactory dysfunction in patients with Parkinson's disease

scientific article published on 05 January 2012

Validation of the sleep related items of the Non-motor Symptoms Questionnaire for Parkinson's disease (NMSQuest).

scientific article published on 7 March 2008

List of works by Santiago Perez-Lloret

A Pilot Cross-Sectional Study to Investigate the Biomarker Potential of Phosphorylated Neurofilament-H and Immune Mediators of Disability in Patients With 5 Year Relapsing-Remitting Multiple Sclerosis

A cross-sectional study on drug use in multiple system atrophy

A double blind-placebo controlled study on melatonin efficacy to reduce anxiolytic benzodiazepine use in the elderly

A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patients ⬇️

A multi-step pathway connecting short sleep duration to daytime somnolence, reduced attention, and poor academic performance: an exploratory cross-sectional study in teenagers

A multifactorial study on nutritional status, binge eating and physical activity as main factors directly influencing body weight in Parkinson's disease

A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson’s disease

Actigraphic evaluation of motor fluctuations in patients with Parkinson's disease

Activity-rest rhythm abnormalities in Parkinson's disease patients are related to dopaminergic therapy

Addenbrooke's Cognitive Examination validation in Parkinson's disease

Adverse drug reactions to dopamine agonists: a comparative study in the French Pharmacovigilance Database

Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease: an old drug revisited ⬇️

Assessment of Ataxia Rating Scales and Cerebellar Functional Tests: Critique and Recommendations

Associations Between Cardiovascular Events and Nonergot Dopamine Agonists in Parkinson's Disease

Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease

Autosomal dominant cerebellar ataxias: a systematic review of clinical features

Brief review: diurnal rhythms, obesity and educational achievement in South american cultures.

Cardiac autonomic activity predicts dominance in verbal over spatial reasoning tasks: Results from a preliminary study ⬇️

Cerebroventricular administration of interferon-gamma modifies locomotor activity in the golden hamster

Comparison of Olfactory Identification Patterns among Parkinson's Disease Patients from Different Countries.

Correction to: Excessive buccal saliva in patients with Parkinson's disease of the French COPARK cohort

Current Concepts in the Treatment of Multiple System Atrophy

Decision-making in Parkinson's disease patients with and without pathological gambling

Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease

Design and development of a novel supportive care product for the treatment of sialorrhea in Parkinson's disease

Disruption of ultradian and circadian rhythms of blood pressure in nondipper hypertensive patients

Do Parkinson’s disease patients disclose their adverse events spontaneously? ⬇️

Does clinical intolerance to a diagnostic acute levodopa challenge differentiate multiple system atrophy from PD?

Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinsonʼs Disease

Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases

Drug-induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France

Drugs associated with restless legs syndrome: a case/noncase study in the French Pharmacovigilance Database

Dyskinesias induced by subthalamotomy in Parkinson's disease are unresponsive to amantadine

Effect of melatonin on changes in locomotor activity rhythm of Syrian hamsters injected with beta amyloid peptide 25-35 in the suprachiasmatic nuclei

Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia

Emerging analgesic drugs for Parkinson's disease ⬇️

Emerging drugs for autonomic dysfunction in Parkinson's disease ⬇️

Excessive buccal saliva in patients with Parkinson's disease of the French COPARK cohort

Factors related to orthostatic hypotension in Parkinson's disease

Falls in ambulatory non-demented patients with Parkinson's disease

Gender differences in age-related increase of asleep blood pressure.

Heart rate nonlinear dynamics during sudden hypoxia at 8230 m simulated altitude

Infradian awake and asleep systolic and diastolic blood pressure rhythms in humans

Investigational drugs for autonomic dysfunction in Parkinson's disease

Irritability, psychomotor agitation and progressive insomnia induced by bilateral stimulation of the area surrounding the dorsal subthalamic nucleus (zona incerta) in Parkinson's disease patients

L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey

Management of constipation in Parkinson's disease

Movement Disorders After Exposure to Antipsychotic Drugs in Patients With Depressive Disorders

Movement Disorders in Autosomal Dominant Cerebellar Ataxias: A Systematic Review.

New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study.

New treatments for levodopa-induced motor complications

Nocturnal hypertension defined by fixed cut-off limits is a better predictor of left ventricular hypertrophy than non-dipping

Non-ergot dopamine agonists and the risk of heart failure and other adverse cardiovascular reactions in Parkinson's disease

Nonmotor symptoms groups in Parkinson's disease patients: results of a pilot, exploratory study

Olfactory Dysfunction Evaluation Is Not Affected by Comorbid Depression in Parkinson's Disease

Oro‐buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson’s disease: preliminary analysis from the French COPARK cohort ⬇️

Parkinson disease: Serotonin reuptake inhibitors for depression in PD.

Parkinson's Disease in the Era of a Novel Respiratory Virus Pandemic

Parkinson's disease sleep scale, sleep logs, and actigraphy in the evaluation of sleep in parkinsonian patients

Pharmacotherapies for Parkinson's disease symptoms related to cholinergic degeneration

Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease

Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease ⬇️

Pramipexole for the treatment of early Parkinson’s disease ⬇️

Predictors of Cardiovascular Autonomic Neuropathy Onset and Progression in a Cohort of Type 1 Diabetic Patients.

Pregabalin Beneficial Effects on Sleep Quality or Health-Related Quality of Life Are Poorly Correlated With Reduction on Pain Intensity After an 8-Week Treatment Course ⬇️

Pregabalin-induced parkinsonism: a case report

Prevalence and Pharmacological Factors Associated With Impulse-Control Disorder Symptoms in Patients With Parkinson Disease ⬇️

Prevalence and factors related to orthostatic syndromes in recently diagnosed, drug-naïve patients with Parkinson disease

Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease

Prospective randomized 1-year follow-up comparison of bilateral subthalamotomy versus bilateral subthalamic stimulation and the combination of both in Parkinson's disease patients: a pilot study.

Rating Scales for Pain in Parkinson's Disease: Critique and Recommendations

Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson's disease

Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients

Role of Astrocytic Dysfunction in the Pathogenesis of Parkinson's Disease Animal Models from a Molecular Signaling Perspective

Rotigotine transdermal delivery for the treatment of Parkinson's disease

Rotigotine transdermal patch for the treatment of Parkinson’s Disease ⬇️

Safety of rasagiline for the treatment of Parkinson's disease ⬇️

Sensory abnormalities and pain in Parkinson disease and its modulation by treatment of motor symptoms

Sleep disordered breathing and daytime sleepiness are associated with poor academic performance in teenagers. A study using the Pediatric Daytime Sleepiness Scale (PDSS).